West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services (NYSE: WST), a leading provider of injectable drug administration solutions, has announced its participation in two upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
West Pharmaceutical Services (NYSE: WST), a leading provider of injectable drug administration solutions, has announced its participation in two upcoming investor conferences. The company will present at the BofA Securities Annual Healthcare Conference on May 14, 2025, at 2:20 PM PT, and at the William Blair 45th Annual Growth Stock Conference on June 5, 2025, at 10:40 AM CT. Live audio webcasts will be accessible through the company's website's "Investors" section, with replays available for approximately 90 days following the events.
Details
News Market Reaction – WST
The recorded move for WST in the trading session of this news was +0.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
It will also present at the William Blair 45th Annual Growth Stock Conference on Thursday, June 5, 2025 at 10:40 AM CT.
A live audio webcast of these events will be available in the "Investors" section of the Company's website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.
Headquartered in
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-participate-in-upcoming-investor-conferences-302449075.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.